Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Uterine Fibroid Embolization Agents market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Uterine Fibroid Embolization Agentsmarket, defines the market attractiveness level of Uterine Fibroid Embolization Agents market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Uterine Fibroid Embolization Agents industry, describes the types of Uterine Fibroid Embolization Agents market, the applications of major players and the market size, and deeply analyzes the current situation of the global Uterine Fibroid Embolization Agents market and the development prospects and opportunities of Uterine Fibroid Embolization Agents industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Uterine Fibroid Embolization Agents market in Chapter 13.
By Player:
Astellas Pharma
Nippon Kayaku
Boston Scientific Corporation
Merit Medical Systems
Pfizer
Cook Medical
By Type:
Gelatin Sponge
Polyvinyl Alcohol (PVA) Particles
Trisacryl Gelatin Microspheres (TAGM)
Polymethyl Methacrylate (PMMA) Microspheres
Others
By End-User:
Clinical Research Institutes
Hospital
Surgical Centers
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Uterine Fibroid Embolization Agents Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Uterine Fibroid Embolization Agents Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Uterine Fibroid Embolization Agents Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Uterine Fibroid Embolization Agents Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Uterine Fibroid Embolization Agents Market Analysis and Outlook to 2022
-
7.1 Global Uterine Fibroid Embolization Agents Consumption (2017-2022)
-
7.2 United States Uterine Fibroid Embolization Agents Consumption (2017-2022)
-
7.3 Europe Uterine Fibroid Embolization Agents Consumption (2017-2022)
-
7.4 China Uterine Fibroid Embolization Agents Consumption (2017-2022)
-
7.5 Japan Uterine Fibroid Embolization Agents Consumption (2017-2022)
-
7.6 India Uterine Fibroid Embolization Agents Consumption (2017-2022)
-
7.7 South Korea Uterine Fibroid Embolization Agents Consumption (2017-2022)
8 Region and Country-wise Uterine Fibroid Embolization Agents Market Analysis and Outlook to 2028
-
8.1 Global Uterine Fibroid Embolization Agents Consumption Forecast (2022-2028)
-
8.2 United States Uterine Fibroid Embolization Agents Consumption Forecast (2022-2028)
-
8.3 Europe Uterine Fibroid Embolization Agents Consumption Forecast (2022-2028)
-
8.4 China Uterine Fibroid Embolization Agents Consumption Forecast (2022-2028)
-
8.5 Japan Uterine Fibroid Embolization Agents Consumption Forecast (2022-2028)
-
8.6 India Uterine Fibroid Embolization Agents Consumption Forecast (2022-2028)
-
8.7 South Korea Uterine Fibroid Embolization Agents Consumption Forecast (2022-2028)
9 Global Uterine Fibroid Embolization Agents Market Outlook by Types and Applications to 2022
-
9.1 Global Uterine Fibroid Embolization Agents Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Gelatin Sponge Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Polyvinyl Alcohol (PVA) Particles Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Trisacryl Gelatin Microspheres (TAGM) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Polymethyl Methacrylate (PMMA) Microspheres Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Uterine Fibroid Embolization Agents Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinical Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Surgical Centers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Uterine Fibroid Embolization Agents Market Outlook by Types and Applications to 2028
-
10.1 Global Uterine Fibroid Embolization Agents Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Gelatin Sponge Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Polyvinyl Alcohol (PVA) Particles Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Trisacryl Gelatin Microspheres (TAGM) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Polymethyl Methacrylate (PMMA) Microspheres Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Uterine Fibroid Embolization Agents Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinical Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Uterine Fibroid Embolization Agents Import and Export Analysis (Top 5 Countries)
-
11.1 Global Uterine Fibroid Embolization Agents Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Uterine Fibroid Embolization Agents Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Uterine Fibroid Embolization Agents Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Uterine Fibroid Embolization Agents Market Competitive Analysis
-
14.1 Astellas Pharma
-
14.1.1 Astellas Pharma Company Details
-
14.1.2 Astellas Pharma Uterine Fibroid Embolization Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Astellas Pharma Uterine Fibroid Embolization Agents Product and Service
-
14.2 Nippon Kayaku
-
14.2.1 Nippon Kayaku Company Details
-
14.2.2 Nippon Kayaku Uterine Fibroid Embolization Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Nippon Kayaku Uterine Fibroid Embolization Agents Product and Service
-
14.3 Boston Scientific Corporation
-
14.3.1 Boston Scientific Corporation Company Details
-
14.3.2 Boston Scientific Corporation Uterine Fibroid Embolization Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Boston Scientific Corporation Uterine Fibroid Embolization Agents Product and Service
-
14.4 Merit Medical Systems
-
14.4.1 Merit Medical Systems Company Details
-
14.4.2 Merit Medical Systems Uterine Fibroid Embolization Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merit Medical Systems Uterine Fibroid Embolization Agents Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Uterine Fibroid Embolization Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Uterine Fibroid Embolization Agents Product and Service
-
14.6 Cook Medical
-
14.6.1 Cook Medical Company Details
-
14.6.2 Cook Medical Uterine Fibroid Embolization Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Cook Medical Uterine Fibroid Embolization Agents Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Uterine Fibroid Embolization Agents
-
Figure Uterine Fibroid Embolization Agents Picture
-
Table Global Uterine Fibroid Embolization Agents Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Uterine Fibroid Embolization Agents Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Uterine Fibroid Embolization Agents Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Uterine Fibroid Embolization Agents Consumption by Country (2017-2022)
-
Figure United States Uterine Fibroid Embolization Agents Consumption and Growth Rate (2017-2022)
-
Table Europe Uterine Fibroid Embolization Agents Consumption and Growth Rate (2017-2022)
-
Figure China Uterine Fibroid Embolization Agents Consumption and Growth Rate (2017-2022)
-
Figure Japan Uterine Fibroid Embolization Agents Consumption and Growth Rate (2017-2022)
-
Figure India Uterine Fibroid Embolization Agents Consumption and Growth Rate (2017-2022)
-
Figure South Korea Uterine Fibroid Embolization Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Uterine Fibroid Embolization Agents Consumption Forecast by Country (2022-2028)
-
Figure United States Uterine Fibroid Embolization Agents Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Uterine Fibroid Embolization Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Uterine Fibroid Embolization Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Uterine Fibroid Embolization Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Uterine Fibroid Embolization Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Uterine Fibroid Embolization Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gelatin Sponge Consumption and Growth Rate (2017-2022)
-
Figure Global Polyvinyl Alcohol (PVA) Particles Consumption and Growth Rate (2017-2022)
-
Figure Global Trisacryl Gelatin Microspheres (TAGM) Consumption and Growth Rate (2017-2022)
-
Figure Global Polymethyl Methacrylate (PMMA) Microspheres Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinical Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Gelatin Sponge Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Polyvinyl Alcohol (PVA) Particles Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Trisacryl Gelatin Microspheres (TAGM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Polymethyl Methacrylate (PMMA) Microspheres Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinical Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Uterine Fibroid Embolization Agents Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Uterine Fibroid Embolization Agents Export by Region (Top 5 Countries) (2017-2028)
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Uterine Fibroid Embolization Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Uterine Fibroid Embolization Agents Product and Service
-
Table Nippon Kayaku (Foundation Year, Company Profile and etc.)
-
Table Nippon Kayaku Uterine Fibroid Embolization Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nippon Kayaku Uterine Fibroid Embolization Agents Product and Service
-
Table Boston Scientific Corporation (Foundation Year, Company Profile and etc.)
-
Table Boston Scientific Corporation Uterine Fibroid Embolization Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boston Scientific Corporation Uterine Fibroid Embolization Agents Product and Service
-
Table Merit Medical Systems (Foundation Year, Company Profile and etc.)
-
Table Merit Medical Systems Uterine Fibroid Embolization Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merit Medical Systems Uterine Fibroid Embolization Agents Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Uterine Fibroid Embolization Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Uterine Fibroid Embolization Agents Product and Service
-
Table Cook Medical (Foundation Year, Company Profile and etc.)
-
Table Cook Medical Uterine Fibroid Embolization Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cook Medical Uterine Fibroid Embolization Agents Product and Service
-
